Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

Clinical trial NCT03445468 · COMPLETED

Trial details

NCT number: NCT03445468
Sponsor: Il-Yang Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2017-09-20
Primary completion: 2017-12-29
Enrollment: 379

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.